Coronavirus & Atopic Dermatitis Reporting Database

Given the interest in the emerging and evolving coronavirus (COVID-19) pandemic and the questions regarding how this will impact patients with atopic dermatitis (AD, syn. atopic eczema), we created a secure, online, de-identified Personal Health Identifier (PHI)-free reporting registry.

We encouraged clinicians worldwide to report cases of COVID-19 in their AD patients, treated with or without systemic immunomodulating medication, regardless of severity (including asymptomatic patients detected through public health screening).